— GROWTH STRATEGY • Venturing & Innovation
The next growth platform has to be built
before you need it.
The organizations that compound growth over time don't wait for the current model to plateau. They build alongside it — finding the right bets early, and building the capability to act on them repeatedly.
— THE WORK
Two distinct problems. Most organizations solve one. Few solve both.
The first problem is finding the right innovations to pursue — identifying where the next platform is forming before the window closes, and building the strategy to get there.
The second is building the organizational capability to do it repeatedly — governance, process, and operating model that turns a one-time venturing commitment into a compounding innovation capability.
Vaxa works on both. The approach to each is different. The connection between them is what makes either one durable.
Finding the right bets
Identifying the technology horizons, market adjacencies, and structural shifts worth pursuing — before they are obvious enough that others have moved.
Building the capability to act
The governance, intake criteria, and conversion pathways that make corporate innovation a repeatable capability — not a pilot that never scales.
The connection between them
Innovation capability without strategic direction produces a portfolio of interesting experiments. Strategic direction without capability produces a plan that never executes.
Strategic Innovation
Vaxa's proprietary process — applied inside some of the world's largest innovation-led organizations.
01
Future Foresight
Reading the signals that precede structural market shifts — technology trajectories, venture activity, regulatory movement, and adjacency patterns — before they consolidate into trends others can see.
02
Market Insights
Understanding where the opportunity actually sits — the unmet needs, underserved segments, and white space that define where a new platform can take hold and grow.
03
Strategic Alignment
Connecting the external opportunity to where the organization can credibly go — capabilities, assets, and appetite that make the innovation bet executable, not just attractive.
"The question is never whether innovation is important. It is whether the organization has the process and the will to pursue the right innovations — before the window closes and others have moved."
SELECTED Strategic innovation CLIENT CASES
See how we helped create new markets through future foresight in telecommunications, consumer goods and advanced glass technologies
SOME CLIENT Outcomes we work toward
Four specific example outputs you can act on.
01
Early warning on market shifts.
A view of the technology, funding and regulatory changes that matter to your markets, so you see them before competitors do.
02
A ranked time-based map of white spaces.
Where new opportunities exist, how big each one is, when it is likely to open, and how well it fits your business.
03
New uses for existing assets you own.
Technology, patents, facilities or data that could serve other markets, each with a business case.
04
Partner ecosystem built for success.
The specific startups, investors and partners worth approaching for each opportunity.
BUILDING THE CAPABILITY
Innovation that compounds requires more than a good strategy. It requires a repeatable, flexible and dynamic operating model.
01
Investment thesis and portfolio design
A clear, defensible statement of the growth bets worth making — the technology horizons and market adjacencies that will define the next platform. Built before the first investment, not after.
02
Governance and decision rights
Who decides what, at which stage, and on what criteria. The structure that allows innovation to move at the speed it requires — without losing organizational coherence.
03
Intake and qualification process
How opportunities enter the funnel, how they are evaluated against the thesis, and which ones earn the investment of time and resource to develop further.
04
Conversion — from pilot to platform
Most corporate innovation fails at the transition from pilot to scale. Vaxa designs the conversion pathway — the conditions, triggers, and organizational design that makes scaling possible.
— Ecosystem Access
Get access to Vaxa's ecosystems of Investors and Startups across all Industries.
The ventures worth backing don't wait for corporate programs to find them. Vaxa's ecosystem network puts them in reach before they are.
INVESTOR TYPES
350,000
VC, Corporate Venture Capital, PE, Soverign Funds, Family Offices
STARTUP COMPANIES
900,000
All stages: Pre-seed, Seed, All Series to pre-IPO
Technology domains
50+ Domains
AI/ML · Biotechnology · Genomics & Gene Editing · Advanced Materials · Clean Energy · Quantum Computing · Robotics & Automation · Digital Health · Semiconductors · Space Technology · Agritech · Fintech · Medtech · Cybersecurity · Climate Tech, and more
INDUSTRIES
20+
Enterprise Software · Life Sciences · Consumer Goods · Telecommunications · Financial Services · Energy · Automotive · Healthcare · Industrial · Retail · Media & Entertainment · Logistics · Real Estate · Education · Defence, and more
A Vaxa On Application
Built for the way a corporate venture team actually needs intelligence
Vaxa On, applied to the corporate venture mandate — continuous visibility into deal flow, portfolio performance, and market signals, not a one-time study that's out of date by the next board meeting.
Deal Sourcing
Continuous scanning of the startup landscape for opportunities that match your thesis, surfaced before they're competitive bidding wars.
Portfolio Monitoring
Ongoing visibility into portfolio company performance and risk signals — not a quarterly check-in that's already stale.
Co-Investment & Syndication
Visibility into who else is already in a deal, and the relationships to act on it before the round closes.
Market & Technology Signals
Early detection of the shifts that change where the fund's next bet should go — before they're consensus.
Stay ahead of what's forming. Subscribe to Vaxa Insights — our look at the critical issues and emerging opportunities facing businesses today.